 |
Adam Bonislawski is the editor of GenomeWeb's ProteoMonitor. He covers proteomics and life science mass spectrometry. E-mail Adam Bonislawski and follow his GenomeWeb Twitter account at @ProteoMonitor. |
MALDI, Other Surface Sampling Methods Continue to Make Inroads in Clinical, Quantitative Proteomics
November 09, 2012
MALDI, Other Surface Sampling Methods Continue to Make Inroads in Clinical, Quantitative Proteomics
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Mass Spec Informatics and Applications Take Center Stage at ASMS 2012
May 25, 2012 / ProteoMonitor - Immundiagnostik Deal Offers Thermo Fisher Chance to Highlight Immunoaffinity Mass Spec Workflows
October 26, 2012 / ProteoMonitor - BRIMS-Led Study Suggests Clinical Viability of SRM-MS, Vendors' Role in Clinical Proteomics Process
June 8, 2012 / ProteoMonitor - New Products: ASMS 2012 Focus
May 25, 2012 / ProteoMonitor - Bruker, SISCAPA Assay Tech Study Suggests MALDI-MS Suitable for Clinical Protein Quantitation
January 30, 2012 / ProteoMonitor